Cirrhotic cardiomyopathy: An independent prognostic factor for cirrhotic patients.
作者信息
Lee Yun Bin, Lee Jeong-Hoon
机构信息
Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea.
出版信息
Clin Mol Hepatol. 2018 Dec;24(4):372-373. doi: 10.3350/cmh.2018.0098. Epub 2018 Dec 11.
Abstract
摘要
相似文献
1
Cirrhotic cardiomyopathy: An independent prognostic factor for cirrhotic patients.肝硬化心肌病：肝硬化患者的一个独立预后因素。
Clin Mol Hepatol. 2018 Dec;24(4):372-373. doi: 10.3350/cmh.2018.0098. Epub 2018 Dec 11.
2
The diagnostic and prognostic value of serum endocan in patients with cirrhotic cardiomyopathy.血清内皮糖蛋白在肝硬化性心肌病患者中的诊断和预后价值。
Rom J Intern Med. 2018 Sep 1;56(3):182-192. doi: 10.2478/rjim-2018-0007.
3
An update on cirrhotic cardiomyopathy.肝硬化性心肌病研究进展。
Expert Rev Gastroenterol Hepatol. 2019 May;13(5):497-505. doi: 10.1080/17474124.2019.1587293. Epub 2019 Mar 8.
4
[Cirrhotic cardiomyopathy].[肝硬化性心肌病]
Korean J Hepatol. 2007 Mar;13(1):20-6.
5
Cirrhotic Cardiomyopathy After Transplantation: Neither the Transient Nor Innocent Bystander.移植后肝硬化性心肌病：既非短暂亦非无辜旁观者。
Hepatology. 2018 Nov;68(5):2008-2015. doi: 10.1002/hep.30040. Epub 2018 Oct 13.
6
Cirrhotic cardiomyopathy: the liver affects the heart.肝硬化性心肌病：肝脏影响心脏。
Braz J Med Biol Res. 2019 Feb 14;52(2):e7809. doi: 10.1590/1414-431X20187809.
7
Cirrhotic cardiomyopathy in the pre- and post-liver transplantation phase.肝移植前后阶段的肝硬化性心肌病
J Cardiol. 2016 Feb;67(2):125-30. doi: 10.1016/j.jjcc.2015.04.016. Epub 2015 Jun 11.
8
Cirrhotic cardiomyopathy.肝硬化性心肌病
Orphanet J Rare Dis. 2007 Mar 27;2:15. doi: 10.1186/1750-1172-2-15.
9
[Cardiomyopathy in liver cirrhosis--an undiagnosed entity?].[肝硬化中的心肌病——一种未被诊断的病症？]
Rev Med Chir Soc Med Nat Iasi. 2010 Apr-Jun;114(2):319-26.
10
Cirrhotic cardiomyopathy.肝硬化性心肌病
Semin Liver Dis. 2008 Feb;28(1):59-69. doi: 10.1055/s-2008-1040321.
引用本文的文献
1
Preoperative Evaluation of Coronary Artery Disease in Liver Transplant Candidates: Many Unanswered Questions in Clinical Practice.肝移植候选者冠状动脉疾病的术前评估：临床实践中诸多未解决的问题
Diagnostics (Basel). 2021 Jan 5;11(1):75. doi: 10.3390/diagnostics11010075.
2
Cardiac Imaging in Liver Transplantation Candidates: Current Knowledge and Future Perspectives.肝移植候选者的心脏成像：当前认知与未来展望
J Clin Med. 2019 Dec 3;8(12):2132. doi: 10.3390/jcm8122132.
本文引用的文献
1
Cardiac diastolic dysfunction predicts poor prognosis in patients with decompensated liver cirrhosis.心脏舒张功能障碍可预测失代偿期肝硬化患者的预后不良。
Clin Mol Hepatol. 2018 Dec;24(4):409-416. doi: 10.3350/cmh.2018.0034. Epub 2018 Aug 27.
2
Myocardial extracellular volume quantified by magnetic resonance is increased in cirrhosis and related to poor outcome.磁共振定量检测的心肌细胞外容积在肝硬化中增加，并与不良预后相关。
Liver Int. 2018 Sep;38(9):1614-1623. doi: 10.1111/liv.13870. Epub 2018 May 21.
3
Nonalcoholic fatty liver disease and advanced fibrosis are associated with left ventricular diastolic dysfunction.非酒精性脂肪性肝病和肝纤维化与左心室舒张功能障碍有关。
Atherosclerosis. 2018 May;272:137-144. doi: 10.1016/j.atherosclerosis.2018.03.027. Epub 2018 Mar 17.
4
New insights into cirrhotic cardiomyopathy.肝硬化性心肌病的新见解。
Int J Cardiol. 2013 Aug 20;167(4):1101-8. doi: 10.1016/j.ijcard.2012.09.089. Epub 2012 Oct 4.
5
Cirrhotic cardiomyopathy.肝硬化性心肌病。
J Am Coll Cardiol. 2010 Aug 10;56(7):539-49. doi: 10.1016/j.jacc.2009.12.075.
6
Cirrhotic cardiomyopathy.肝硬化性心肌病。
J Hepatol. 2010 Jul;53(1):179-90. doi: 10.1016/j.jhep.2010.02.023. Epub 2010 Mar 31.
7
Evidence of functional and structural cardiac abnormalities in cirrhotic patients with and without ascites.有腹水和无腹水的肝硬化患者心脏功能和结构异常的证据。
Hepatology. 1997 Nov;26(5):1131-7. doi: 10.1002/hep.510260507.
8
Renal functional reserve and nitric oxide in patients with compensated liver cirrhosis.
Hepatology. 1997 Oct;26(4):858-64. doi: 10.1002/hep.510260409.
9
Hyperdynamic circulation of advanced cirrhosis: a re-appraisal based on posture-induced changes in hemodynamics.晚期肝硬化的高动力循环：基于体位引起的血流动力学变化的重新评估。
J Hepatol. 1995 Mar;22(3):309-18. doi: 10.1016/0168-8278(95)80284-3.
Zotero 插件